Targeting BTK in CLL: Expert Guidance on Selecting Single-Agent and Combination Therapy

Download All
Learn how global experts plan optimal BTK inhibitor–based therapy for patients with CLL with downloadable slides and an on-demand webcast from the CCO webinar at the 2021 XIX iwCLL Congress.
person default
Seema Ali Bhat, MD
Talha Munir, MBBS, MRCP, FRCPath

Downloadable Slides and Clinical ExpressPoints

Download this slideset on the current role of BTK inhibitors in the treatment of patients with CLL.

person default Seema Ali Bhat, MD Talha Munir, MBBS, MRCP, FRCPath Released: September 27, 2021

Download this short summary slideset of key takeaway points from a live presentation on BTK inhibitors in the treatment of CLL.

person default Seema Ali Bhat, MD Talha Munir, MBBS, MRCP, FRCPath Released: November 4, 2021

On-Demand Webcast

Watch this on-demand webcast of a live CCO webinar where global experts discuss the latest advances in the use of BTK inhibitors in managing patients with CLL.

person default Seema Ali Bhat, MD Talha Munir, MBBS, MRCP, FRCPath Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: December 10, 2021 Expired: December 9, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings